March 24, 2017
Recommended Topic Related To:


"An experimental oral lymphocyte trafficking agent, ozanimod (Receptos), showed modest activity against ulcerative colitis (UC) in a small, early-stage clinical trial.

In the double-blind, placebo-controlled phase 2 trial in adults wit"...




  • Instruct patients to swallow the DELZICOL capsule whole with water, taking care not to open, break, crush, or chew the capsules, because the coating is an important part of the delayed-release formulation.
    Instruct patients to contact their physician if they are unable to swallow the DELZICOL capsules whole.
  • Inform patients that if they are switching from a previous oral mesalamine therapy to DELZICOL they should discontinue their previous oral mesalamine therapy and follow the dosing instructions for DELZICOL. Inform patients that intact, partially intact, and/or capsule shells have been reported in the stool. Instruct patients to contact their physician if this occurs repeatedly.
  • Instruct patients to protect DELZICOL from moisture. Instruct patients to close the container tightly and to leave any desiccant pouches present in the bottle along with the capsules.

Last reviewed on RxList: 1/18/2017
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.